TECHLAB featured as a leader in infectious disease diagnostics
TECHLAB was recently featured on the website of the Valleys Innovation Council. Check out the article at https://www.valleysinnovation.org/techlab/ &nbs… Continue reading
NEWS
What we are up to:
TECHLAB participates in VT Corporate Research Center Media Day
On Tuesday, September 17, TECHLAB participated in the Virginia Tech Corporate Research Center’s Media Day event. We welcomed media representatives to TECHLAB to learn about our company history, the science behind our products, and our plans to grow in the future. CEO Dan Delaney and COO Rob Day explained that TECHLAB was founded in 1989 … Continue reading
PRESS RELEASE: TECHLAB® Receives FDA 510(k) Clearance to Market H. PYLORI QUIK CHEK™ and H. PYLORI CHEK™ Tests
BLACKSBURG, Va. – Aug. 21, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received U.S. Food and Drug Administration (FDA) clearance for the H. PYLORI QUIK CHEK™ and the H. PYLORI CHEK™ tests. Both are designed to aid in the diagnosis of H. … Continue reading
PRESS RELEASE: TECHLAB® Products Identified As Meeting Updated Clinical Practice Guidelines For Clostridium Difficile Infection
BLACKSBURG, Va. – Feb. 26, 2018 – TECHLAB®, Inc., today announced its products meet the updated Clinical Practice Guidelines for Clostridium difficile from The Infectious Disease Society of America (IDSA) and the Society of Healthcare Epidemiology of America (SHEA). The new recommendations recently published in the journal Clinical Infectious Diseases, emphasize the value of immunoassay toxin … Continue reading
PRESS RELEASE: TECHLAB® Receives FDA 510(k) Clearance to Market CAMPYLOBACTER QUIK CHEK™ and CAMPYLOBACTER CHEK™ Tests
BLACKSBURG, Va. – January 23, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received U.S. Food and Drug Administration (FDA) clearance for the CAMPYLOBACTER QUIK CHEK™ and the CAMPYLOBACTER CHEK™ tests. Both are intended to aid diagnosis of campylobacteriosis, one of the most common … Continue reading
PRESS RELEASE: Phoenix Lab to Offer GIARDIA VET CHEK™ From TECHLAB®
BLACKSBURG, Va. and MUKILTEO, Wash. – January 11, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received a USDA establishment license and product license for GIARDIA VET CHEK™. The test qualitatively detects Giardia cyst antigen in canine and feline fecal samples and is the … Continue reading
PRESS RELEASE: Advanced Veterinary Laboratory to Offer GIARDIA VET CHEK™ From TECHLAB®
BLACKSBURG, Va. – January 3, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it will supply Advanced Veterinary Laboratory (AVL) with the GIARDIA VET CHEK™ test, the first USDA licensed Giardia microwell ELISA available for use in dogs and cats. The GIARDIA VET CHEK™ test offers … Continue reading
PRESS RELEASE: TECHLAB® Receives USDA Establishment License and Product License for GIARDIA VET CHEK™
BLACKSBURG, Va. – November 8, 2017 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received a USDA establishment license and product license for GIARDIA VET CHEK™. The test qualitatively detects Giardia cyst antigen in canine and feline fecal samples and is the first … Continue reading
PRESS RELEASE: TECHLAB® Receives FDA 510(k) Clearance To Market TRI-COMBO PARASITE SCREEN™ To Aid Clinicians In The Diagnosis Of Giardiasis, Cryptosporidiosis, And Amebiasis
Read the full release here. BLACKSBURG, Va., July 13, 2017 /PRNewswire/ — TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received U.S. Food and Drug Administration (FDA) clearance for the TRI-COMBO PARASITE SCREEN™ test. The TRI-COMBO PARASITE SCREEN ™ test provides a complete analysis for Giardia, Cryptosporidium, and Entamoeba histolytica, the three most common intestinal protozoan … Continue reading
PRESS RELEASE: TECHLAB® Receives FDA 510(k) Clearance To Market E. HISTOLYTICA QUIK CHEK™ To Aid Clinicians In The Diagnosis Of Amebiasis Caused By The E. Histolytica Parasite
Read the full release here. BLACKSBURG, Va., June 13, 2017 /PRNewswire/ — TECHLAB®,® Inc., a leading developer and manufacturer of rapid, non-invasive diagnostic tests for gastrointestinal disease, today announced that it received U.S. Food and Drug Administration (FDA) clearance for E. HISTOLYTICA QUIK CHEK™ test. E. HISTOLYTICA QUIK CHEK™ test is the only rapid diagnostic test that specifically detects pathogenic E. histolytica and does not … Continue reading
